V029-3150 Screening compound: 2-[4-(4-methoxybenzoyl)piperazin-1-yl]-6-{[4-(4-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one

V029-3150 Screening compound: 2-[4-(4-methoxybenzoyl)piperazin-1-yl]-6-{[4-(4-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one
V029-3150 Screening compound: 2-[4-(4-methoxybenzoyl)piperazin-1-yl]-6-{[4-(4-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-3150
2-[4-(4-methoxybenzoyl)piperazin-1-yl]-6-{[4-(4-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-3150

Molecular Formula

C28H34N6O3 (C28 H34 N6 O3)

Compound Name

2-[4-(4-methoxybenzoyl)piperazin-1-yl]-6-{[4-(4-methylphenyl)piperazin-1-yl]methyl}-3,4-dihydropyrimidin-4-one

IUPAC name

2-[4-(4-methoxybenzoyl)piperazin-1-yl]-6-{[4-(4-methylphenyl)piperazin-1-yl]methyl}-34-dihydropyrimidin-4-one

SMILES

Cc(cc1)ccc1N1CCN(CC(N=C(N2)N(CC3)CCN3C(c(cc3)ccc3OC)=O)=CC2=O)CC1

InChI

InChI=1S/C28H34N6O3/c1-21-3-7-24(8-4-21)32-13-11-31(12-14-32)20-23-19-26(35)30-28(29-23)34-17-15-33(16-18-34)27(36)22-5-9-25(37-2)10-6-22/h3-10,19H,11-18,20H2,1-2H3,(H,29,30,35)

InChI Key

CZJATOUIKVYPJD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19859961

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

502.62

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.471

Distribution Coefficient, logD

0.970

Water Solubility, LogSw

-2.84

Polar Surface Area

69.356

Acid Dissociation Constant (pKa)

8.87

Base Dissociation Constant (pKb)

7.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.30

V029-3150 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V029-3150 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-3150?
Check Price and Availability of V029-3150, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-3150 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-3150
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-3150
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-3150 available by request